179 related articles for article (PubMed ID: 36297647)
1. Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy.
Neves AR; Albuquerque T; Faria R; Gonçalves AM; Santos C; Vivès E; Boisguérin P; Passarinha LA; Sousa Â; Costa D
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297647
[TBL] [Abstract][Full Text] [Related]
2. Optimization of peptide-plasmid DNA vectors formulation for gene delivery in cancer therapy exploring design of experiments.
Sousa Â; Almeida AM; Faria R; Konate K; Boisguerin P; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2019 Nov; 183():110417. PubMed ID: 31408780
[TBL] [Abstract][Full Text] [Related]
3. Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis.
Neves AR; Sousa A; Faria R; Albuquerque T; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2020 Jan; 185():110610. PubMed ID: 31711736
[TBL] [Abstract][Full Text] [Related]
4. Development of Tailor-Made Dendrimer Ternary Complexes for Drug/Gene Co-Delivery in Cancer.
Neves AR; Albuquerque T; Faria R; Paul M; Biswas S; Sousa Â; Costa D
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452218
[TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.
Wang J; Lei Y; Xie C; Lu W; Yan Z; Gao J; Xie Z; Zhang X; Liu M
Int J Pharm; 2013 Dec; 458(1):48-56. PubMed ID: 24144951
[TBL] [Abstract][Full Text] [Related]
7. A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery.
Youn P; Chen Y; Furgeson DY
Mol Pharm; 2014 Feb; 11(2):486-95. PubMed ID: 24387132
[TBL] [Abstract][Full Text] [Related]
8. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
9. Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy.
Faria R; Paul M; Biswas S; Vivès E; Boisguérin P; Sousa Â; Costa D
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456591
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA delivery using fluorescein-labeled arginine-rich peptides.
Oba M; Demizu Y; Yamashita H; Kurihara M; Tanaka M
Bioorg Med Chem; 2015 Aug; 23(15):4911-4918. PubMed ID: 26048025
[TBL] [Abstract][Full Text] [Related]
11. A co-delivery platform based on plasmid DNA peptide-surfactant complexes: formation, characterization and release behavior.
Costa D; Albuquerque T; Queiroz JA; Valente AJM
Colloids Surf B Biointerfaces; 2019 Jun; 178():430-438. PubMed ID: 30908999
[TBL] [Abstract][Full Text] [Related]
12. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy.
Bao X; Wang W; Wang C; Wang Y; Zhou J; Ding Y; Wang X; Jin Y
Biomaterials; 2014 Sep; 35(29):8450-66. PubMed ID: 24997481
[TBL] [Abstract][Full Text] [Related]
13. Development of Peptide-Based Nanoparticles for Mitochondrial Plasmid DNA Delivery.
Faria R; Vivés E; Boisguerin P; Sousa A; Costa D
Polymers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206125
[TBL] [Abstract][Full Text] [Related]
14. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor targeting segment T7 containing peptide gene delivery vectors for efficient transfection of brain tumor cells.
Kang Z; Zeng C; Tian L; Wang T; Yang S; Cheng Q; Zhang J; Meng Q; Zhang C; Meng Z
Drug Deliv; 2022 Dec; 29(1):2375-2385. PubMed ID: 35866298
[TBL] [Abstract][Full Text] [Related]
16. Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells.
Niu X; Gao Z; Qi S; Su L; Yang N; Luan X; Li J; Zhang Q; An Y; Zhang S
Int J Nanomedicine; 2018; 13():4895-4911. PubMed ID: 30214196
[TBL] [Abstract][Full Text] [Related]
17. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
[TBL] [Abstract][Full Text] [Related]
18. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer.
Sun Z; Huang J; Su L; Li J; Qi F; Su H; Chen Y; Zhang Q; Zhang Q; Li Z; Zhang S
Nanoscale; 2021 Sep; 13(34):14538-14551. PubMed ID: 34473182
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
[TBL] [Abstract][Full Text] [Related]
20. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
Kim SS; Rait A; Kim E; Pirollo KF; Chang EH
Nanomedicine; 2015 Feb; 11(2):301-11. PubMed ID: 25240597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
